Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10352)
All Articles published online
|
Publishing Process of This Article
|
Sep 10, 2019 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nishida T, Iijima H, Adachi S. Immune checkpoint inhibitor-induced diarrhea/colitis: Endoscopic and pathologic findings. World J Gastrointest Pathophysiol 2019; 10(2): 17-28 [PMID: 31559106 DOI: 10.4291/wjgp.v10.i2.17] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i2/17.htm |
| Number | Citing Articles |
| 1 |
Paul T. Kröner, Kabir Mody, Francis A. Farraye. Immune checkpoint inhibitor–related luminal GI adverse events. Gastrointestinal Endoscopy 2019; 90(6): 881 doi: 10.1016/j.gie.2019.09.009
|
| 2 |
Andrea Pagan, Yadis M Arroyo-Martinez, Ankita Tandon , Carlos Bertran-Rodriguez, Jeffrey Gill. Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis. Cureus 2020; doi: 10.7759/cureus.8613
|
| 3 |
Liansha Tang, Jialing Wang, Nan Lin, Yuwen Zhou, Wenbo He, Jiyan Liu, Xuelei Ma. Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.800879
|
| 4 |
Anca Macovei Oprescu, Raluca Tulin, Iulian Slavu, Dana Paula Venter, Constantin Oprescu. Immune Checkpoint Inhibitor-Induced Gastrointestinal Toxicity: The Opinion of a Gastroenterologist. Cureus 2021; doi: 10.7759/cureus.19945
|
| 5 |
Khang Duy Ricky Le, Kay Tai Choy, Sara Roth, Alexander G. Heriot, Joseph C. H. Kong. Immune mediated colitis: a surgical perspective. ANZ Journal of Surgery 2023; 93(6): 1495 doi: 10.1111/ans.18485
|
| 6 |
Xiaonan Tang, Xiang Li, Yufei Wang, ZhiHui Zhang, AnJun Deng, WenJie Wang, Haijing Zhang, Hailin Qin, LianQiu Wu. Butyric Acid Increases the Therapeutic Effect of EHLJ7 on Ulcerative Colitis by Inhibiting JAK2/STAT3/SOCS1 Signaling Pathway. Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01553
|
| 7 |
Kensuke Sakurai, Takehiko Katsurada, Mutsumi Nishida, Satomi Omotehara, Shinya Fukushima, Shinsuke Otagiri, Kazunori Nagashima, Reizo Onishi, Ryo Takagi, Yoshito Komatsu, Naoya Sakamoto. Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis. Intestinal Research 2023; 21(1): 126 doi: 10.5217/ir.2021.00166
|
| 8 |
Ammar Jabbar Hamad, Aseel Jassim Albdairi, Samer Nema Yassen Alkemawy, Safaa Ali Khudair, Noor Rafea Abdulhadi. Assessment of the incidence and etiology of nosocomial diarrhea in a medical ward in Iraq. Journal of Medicine and Life 2022; 15(1): 132 doi: 10.25122/jml-2021-0275
|
| 9 |
Haleh Vaziri, Alla Turshudzhyan, Eric Vecchio. Immunotherapy-induced Colitis. Journal of Clinical Gastroenterology 2022; 56(7): 555 doi: 10.1097/MCG.0000000000001705
|
| 10 |
Angelo Del Gaudio, Federica Di Vincenzo, Valentina Petito, Maria Cristina Giustiniani, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases 2023; doi: 10.1093/ibd/izad229
|
| 11 |
Neeraj Chhabra, Joseph Kennedy. A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors. Journal of Medical Toxicology 2021; 17(4): 411 doi: 10.1007/s13181-021-00833-8
|
| 12 |
Naoya Ozawa, Takehiko Yokobori, Katsuya Osone, Chika Katayama, Kunihiko Suga, Chika Komine, Yuta Shibasaki, Takuya Shiraishi, Takuhisa Okada, Ryuji Kato, Hiroomi Ogawa, Akihiko Sano, Makoto Sakai, Makoto Sohda, Hitoshi Ojima, Tatsuya Miyazaki, Yoko Motegi, Munenori Ide, Takashi Yao, Hiroyuki Kuwano, Ken Shirabe, Hiroshi Saeki. PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92530-3
|
| 13 |
Kazumasa Soma, Tsutomu Nishida, Naoto Osugi, Osamu Morimura, Shiro Adachi, Yoshifumi Fujii, Aya Sugimoto, Kaori Mukai, Dai Nakamatsu, Kengo Matsumoto, Masashi Yamamoto. Nivolumab dose escalation triggered immune checkpoint inhibitor-induced colitis after 147 weeks of prolonged stable use in a patient with lung cancer: a case report. Clinical Journal of Gastroenterology 2022; 15(1): 128 doi: 10.1007/s12328-021-01542-z
|
| 14 |
Tsvetelina Velikova, Boris Krastev, Milena Gulinac, Miroslav Zashev, Vasko Graklanov, Milena Peruhova. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis. World Journal of Clinical Cases 2024; 12(6): 1050-1062 doi: 10.12998/wjcc.v12.i6.1050
Abstract(100) |
Core Tip(85) |
Full Article(HTML)(648)
|
Full Article with Cover (PDF)-6262K(80)
|
Full Article (Word)-2309K(11)
|
Audio-266K(0)
|
Peer-Review Report-321K(5)
|
Answering Reviewers-199K(27)
|
Supplementary Material-160K(9)
|
Full Article (PDF)-6032K(33)
|
Full Article (XML)-184K(11)
|
Times Cited (0)
|
Total Visits (1334)
|
Open
|
| 15 |
David J. Friedman, Monika Kizerwetter, Paul Belmonte, Matthew Rajcula, Keith Theodore, Hyun Se Kim Lee, Michael J. Shapiro, Haidong Dong, Virginia Smith Shapiro. Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice. The Journal of Immunology 2022; 208(8): 1845 doi: 10.4049/jimmunol.2101165
|
| 16 |
Soichiro Ogawa, Hiroshi Kawakami, Sho Suzuki, Daisuke Kuroki, Naomi Uchiyama, Hiroshi Hatada, Toshihiro Gi, Yuichiro Sato. Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review. Internal Medicine 2021; 60(17): 2783 doi: 10.2169/internalmedicine.6606-20
|
| 17 |
Ngozi Y. Enwerem, Eugene F. Yen. The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis. Current Opinion in Gastroenterology 2024; 40(1): 50 doi: 10.1097/MOG.0000000000000986
|
| 18 |
Takahiro Fuji, Jun Arai, Yumi Otoyama, Yuta Nio, Ikuya Sugiura, Yoko Nakajima, Atsushi Kajiwara, Yuki Ichikawa, Shojiro Uozumi, Yuu Shimozuma, Manabu Uchikoshi, Masashi Sakaki, Hisako Nozawa, Kenji Momo, Tadanori Sasaki, Hitoshi Yoshida. A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review. OncoTargets and Therapy 2022; : 1281 doi: 10.2147/OTT.S383769
|
| 19 |
Rejath Jose, Jasveen Kaur, Theophany Blanco, Samantha Ehrlich , Michael Marcelin. Pembrolizumab-Induced Colitis and Diarrhea in the Treatment of Sporadic Colorectal Cancer: A Case Report. Cureus 2024; doi: 10.7759/cureus.52636
|
| 20 |
Nisanard Pisuchpen, Sienna M. Durbin, Meghan J. Mooradian, Florian J. Fintelmann, Kerry L. Reynolds, Michael Dougan, Avinash Kambadakone. Multi-detector computed tomography (MDCT)–based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis. European Radiology 2021; 31(12): 8868 doi: 10.1007/s00330-021-07925-7
|
| 21 |
Tatsushi Naito, Takuto Nosaka, Kazuto Takahashi, Kazuya Ofuji, Hidetaka Matsuda, Masahiro Ohtani, Katsushi Hiramatsu, Yoshiaki Imamura, Tamotsu Ishizuka, Yasunari Nakamoto. A case of immune checkpoint inhibitor-related colitis with a distinctive endoscopic finding of colonic pseudolipomatosis. Clinical Journal of Gastroenterology 2021; 14(5): 1431 doi: 10.1007/s12328-021-01459-7
|
| 22 |
Xu Han, Dan Zang, Dan Liu, Jun Chen. The multifaceted roles of common gut microbiota in immune checkpoint inhibitor-mediated colitis: From mechanism to clinical application. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.988849
|
| 23 |
Hidezumi Kikuchi, Hirotake Sakuraba, Yui Akemoto, Kazuhiro Hosoi, Yasuhisa Murai, Kentaro Hoshi, Yukari Fukutoku, Taka Asari, Yohei Sawada, Keisuke Hasui, Tetsuya Tatsuta, Hiroto Hiraga, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda. Endoscopic and histopathologic features of Anti‐PD‐1‐related collagenous colitis. DEN Open 2022; 2(1) doi: 10.1002/deo2.92
|
| 24 |
Barbara Hollander, Shruti Khurana, Jake S. Jacob, Melmet Altan, Jianbo Wang, Dan Zhao, Krishnavathana Varatharajalu, Mazen Alasadi, Anusha S. Thomas, Yinghong Wang. Mesalamine and cholestyramine for immune checkpoint inhibitor-mediated diarrhea and colitis. Journal of Cancer Research and Clinical Oncology 2023; 149(7): 3637 doi: 10.1007/s00432-022-04116-9
|
| 25 |
Meihua Liu, Zhonghua Wang, Xuan Liu, Hang Xiao, Yangcheng Liu, Jiaqi Wang, Changlan Chen, Xin Wang, Wei Liu, Zheng Xiang, Dongmei Yue. Therapeutic effect of Yiyi Fuzi Baijiang formula on TNBS-induced ulcerative colitis via metabolism and Th17/Treg cell balance. Journal of Ethnopharmacology 2023; 309: 116301 doi: 10.1016/j.jep.2023.116301
|